Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A

Overview of attention for article published in Biologics: Targets & Therapy, February 2009

Altmetric Badge

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 16 Dimensions

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Immunoglobulin chimeric monomer-dimer hybrids

Grant US-11401322-B2

United States of America

Immunoglobulin chimeric monomer-dimer hybrids

Grant US-11168125-B2

United States of America

Immunoglobulin chimeric monomer-dimer hybrids

Grant US-8932830-B2

United States of America

Clotting factor-Fc chimeric proteins to treat hemophilia

Grant US-8815250-B2

United States of America

Clotting factor-fc chimeric proteins to treat hemophilia

Grant US-8449884-B2

United States of America

Immunoglobulin chimeric monomer-dimer hybrids

Grant US-8329182-B2

United States of America

Immunoglobulin chimeric monomer-dimer hybrids

Grant US-7862820-B2

United States of America

Methods for chemically synthesizing immunoglobulin chimeric proteins

Grant US-7820162-B2

United States of America